Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification
29 April 2022 (08:30 - 17:00)
Organised by: 
Abstract
About the speaker
University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
73 More presentations in this session
Miss E. Bevilacqua (Seville, ES)
Doctor K. Viligorska (Chernivtsi, UA)
Mr C. Rios Navarro (Valencia, ES)
Associate Professor L. Tacu (Chisinau, MD)
Access the full session
The Event
Frontiers in CardioVascular Biomedicine 2022
29 April 2022
08:30 CET
You may be interested in
Congress Session
Congress Session
Congress Session
